Brief: India's Zim Laboratories Posts Sept-Quarter Consol Profit
26/10/2020 11:00
Oct 26 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* INDIA'S ZIM LABORATORIES -SEPT-QUARTER CONSOL PAT 11.9
MILLION
RUPEES VERSUS LOSS 6.1 MILLION RUPEES YEAR AGO
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 880.3 MILLION
RUPEES
VERSUS 677.9 MILLION RUPEES
Source text for Eikon: ID:nBSE9NRdpp
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia